Bayer HealthCare, a subsidiary of Bayer AG (NYSE: BAY), and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that Nexavar? (sorafenib) tablets significantly extended overall survival in patients with hepatocellular carcinoma (HCC), or primary liver cancer versus those taking placebo by 44%.
GlaxoSmithKline (NYSE: GSK) announced that the European Commission approved its novel topical antibacterial ALTARGO? (retapamulin ointment,1%) for the treatment of impetigo and infected small lacerations, abrasions or sutured wounds.
Veterans returning from Iraq and Afghanistan have a wide range of health concerns, including a 55 percent prevalence of mental health issues, reports a study in the May Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Nearly 200 UK MPs, including former government ministers, have joined calls for the government to give nurses this year?s pay award in full, instead of the staged pay cut it is currently proposing.
A University of Melbourne longitudinal family study investigating risk factors for childhood allergic disorders and their consequences, has received $850,000 from the National Health and Medical Research Council, announced by the Commonwealth Government last week.
Researchers at the University of Alberta (Edmonton, AB) and Cortex Pharmaceuticals (Irvine, CA) believe that AMPAKINE drugs may provide protection from drug-induced respiratory depression, while simultaneously allowing the sedative or analgesic to continue working as it was intended.
Risk of congestive heart failure in women treated with trastuzumab (Herceptin) and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31, presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
A drug described by some people as a “genius pill” for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as “chemo-brain,” according to a University of Rochester Medical Center study.
Hospital admissions are up again according to a report released today by the Australian Institute of Health and Welfare (AIHW).
CIGNA HealthCare President David Cordani to lead CIGNA employees in Cancer Challenge Ride; CIGNA to sponsor CIGNA-Calhoun Rider Zone